Mountain and stream

Blog

  • Posted By:

    Steve Parcell

  • Category:

    Intravenous Therapy

Alzheimer’s disease is one of the most prevalent neurodegenerative disorders, affecting millions worldwide. With no cure currently available, researchers are exploring various treatment avenues—including an unexpected candidate: Methylene Blue (MB). What is Methylene Blue? Methylene Blue is a well-known compound with a long history in medicine. Originally used as a dye and antiseptic, it has been FDA-approved for treating conditions like ma...
  • Posted By:

    Steve Parcell

  • Category:

    Alternatives to Prescription Drugs

My top ten supplements for longevity are based on scientific evidence supporting their roles in cellular health, inflammation reduction, mitochondrial function, telomere length, and for disease prevention. 1. Nicotinamide Mononucleotide (NMN) / Nicotinamide Riboside (NR) Boosts NAD⁺ levels, supporting DNA repair, mitochondrial function, and sirtuin activation. May improve metabolism, muscle function, and cognitive health. ...
In the ever-evolving field of health and wellness, innovative therapies that harness the power of light for healing continue to emerge. One such cutting-edge technique is sublingual photobiomodulation, a method that utilizes low-level laser or LED light therapy applied directly under the tongue. This non-invasive therapy has gained attention for its potential to enhance cellular function, improve systemic health, and optimize cognitive performanc...
Chelation therapy is an underappreciated treatment. That is probably because it is not marketed on social media. It is also not new. In fact, there is data on chelation therapy that goes back to the 1980s. There are 281 articles in the medical literature on chelation for cardiovascular disease alone! This article is a quick summary of some of the evidence supporting chelation. Here’s a list of studies supporting various aspects of chelation ...
  • Posted By:

    Denise Clark

  • Category:

    Lyme Disease

It has been well established that up to 30% of patients who are diagnosed and treated for Lyme disease experience post-treatment Lyme disease syndrome (PTLDS). PTLDS is characterized by persistent symptoms that can last for months or years. These symptoms can include fatigue, cognitive impairment, joint and muscle aches, and neuropathy, among others. There are a few factors that contribute to the development of PTLDS and one of them is the abili...